Patent assignee · US · COMPANY

BOSTON BIOMEDICAL, INC.

19Patents
19Active
19Granted
51Portfolio score

Filing activity: Sep 5, 2008 → Aug 16, 2019 · 5 expiring within 5 years

Most-cited patents

PatentTitleAreaCited byStatus
US9745278B2 Group of STAT3 pathway inhibitors and cancer stem cell pathway inhibitors Emerging Cross-Sectional Technologies 6 Active
US8877803B2 Stat3 pathway inhibitors and cancer stem cell inhibitors Emerging Cross-Sectional Technologies 6 Active
US9732055B2 Compositions and methods for cancer treatment Emerging Cross-Sectional Technologies 5 Active
US9730909B2 Methods for targeting cancer stem cells Human Necessities 4 Active
US9834532B2 Stat3 pathway inhibitors and cancer stem cell inhibitors Emerging Cross-Sectional Technologies 4 Active
US9381184B2 Compounds and compositions for targeting cancer stem cells Emerging Cross-Sectional Technologies 4 Active
US9084766B2 Compounds and compositions for targeting cancer stem cells Emerging Cross-Sectional Technologies 4 Active
US10377731B2 Compositions and methods for cancer treatment Emerging Cross-Sectional Technologies 3 Active
US9795595B2 Methods for treating cancer Physics 2 Active
US10017488B2 3-substituted carbonyl-naphtho[2,3-B]furane derivative or pharmaceutically acceptable salt thereof Chemistry; Metallurgy 2 Active
US8299106B2 Compositions of kinase inhibitors and their use for treatment of cancer and other diseases related to kinases Chemistry; Metallurgy 2 Active
US10543189B2 2-acetylnaphtho[2,3-b]furan -4,9-dione for use on treating cancer Human Necessities 1 Active
US10683274B2 3-substituted carbonyl-naphtho[2,3-B]furane derivative or pharmaceutically acceptable salt thereof Chemistry; Metallurgy 1 Active
US9187454B2 Inhibitors of kinases and cancer stem cells, and methods of preparation and use thereof Chemistry; Metallurgy 1 Active
US10646464B2 Methods for treating cancer Human Necessities 1 Active
US10183925B2 Substituted naphtho[2,3-b]furans as water-soluble prodrugs for preventing and/or treating cancer Chemistry; Metallurgy 0 Active
US10800752B2 Substituted naphtho[2,3-b]furans as water-soluble prodrugs for preventing and/or treating cancer Chemistry; Metallurgy 0 Active
US9725444B2 Compositions of kinase inhibitors and their use for treatment of cancer and other diseases related to kinases Chemistry; Metallurgy 0 Active
US9227962B2 Heterocyclic substituted-3-heteroarylidenyl-2-indolinone derivative Chemistry; Metallurgy 0 Active

Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.